A Phase II Single-Arm Study of Therapeutic Iobenguane (131-I) for High-Risk Neuroblastoma at theTime of First Relapse
Conditions: Neuroblastoma; Neuroectodermal Tumors; Neoplasms Intervention: Drug: 131I-MIBG Sponsor: Jubilant DraxImage Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials